Lockebio
Founded 2019 · 9 employees on LinkedIn · 1 known investors
Locke Bio operates a white-labeled digital health platform enabling brands to launch integrated telehealth services with telemedicine consultations, patient intake, pharmacy networks, and payment processing. The platform serves direct-to-consumer brands seeking to distribute prescription drugs and healthcare services with an e-commerce experience.
Founders & leadership
Lockebio was founded in 2019 by Cathy Tie.
Investors · 1
Frequently asked questions
- What does Lockebio do?
- Locke Bio operates a white-labeled digital health platform enabling brands to launch integrated telehealth services with telemedicine consultations, patient intake, pharmacy networks, and payment processing. The platform serves direct-to-consumer brands seeking to distribute prescription drugs and healthcare services with an e-commerce experience.
- Who founded Lockebio?
- Lockebio was founded by Cathy Tie in 2019.
- Who are Lockebio's investors?
- Lockebio's investors include Ten13.